Why the study?
Does extended thromboprophylaxis reduce venous thromboembolism in patients following total hip and knee arthroplasty?
Does extended thromboprophylaxis reduce venous thromboembolism in patients following total hip and knee arthroplasty?
Extended thromboprophylaxis with low-molecular-weight heparins for approximately 4 weeks reduces deep vein thrombosis after total hip arthroplasty, but current data do not support extension beyond 10 days for total knee arthroplasty.
May support 4-week LMWH after hip arthroplasty; leaves open optimal duration after knee and in contemporary practice.
Elective total hip arthroplasty and total knee arthroplasty are associated with a high risk of postoperative venous thromboembolism. Traditionally, antithrombotic prophylaxis has been administered during the hospital stay. However, with patients spending less time in the hospital after surgery, there is a need to continue thromboprophylaxis beyond hospital discharge. The current recommendation for prophylaxis in total joint arthroplasty patients is a minimum of 10 days, with extended prophylaxis up to 28 to 35 days following total hip arthroplasty. Prophylaxis with low-molecular-weight heparins for approximately 4 weeks following hip arthroplasty has resulted in clinically significant reductions in the incidence of venographically confirmed deep vein thrombosis. Currently, no data support extended thromboprophylaxis beyond 10 days following total knee arthroplasty. Using weighted risk factors to assess individual risk for venous thromboembolism can help the physician determine the optimal duration of prophylaxis.
No takes yet. Share an insight, caveat, or question.
Richard J. Friedman (2007) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: